Cell and Gene Therapy: Oncology Clinical Trial Trends in the United States

Cell and gene therapies (CGT) have seen expansive clinical development and revenue growth over the past 5 years across various therapeutic areas. With the approval of 12 new therapies and the initiation of over 2,900 clinical trials between the analysis period of 2016-2021, it is evident there is extensive investment in the innovation of CGT.

The white paper covers:

• Changing B2B sales landscape and new challenges for sales executives
• Key elements of sales intelligence program
• How can sales intelligence benefit sales & marketing?
• What are the must-have KPI’s to measure the success of sales intelligence programs?

Enter your details here to receive your free whitepaper and ready your business for these increasingly uncertain times.